ARCHIVES

RFA/PA/Drug Group Announcement Limited

This article is from The Cancer Letter archive.

Vol. 14 No. 19 | May 6, 1988

Download PDF Visit The Full Archive

Related Articles

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

In Brief: Durant To Retire From ASCO In A Year; Led Society Through Management Change

July 24, 1998

NCI Programs: Functional Imaging Centers Grant Program Approved By Advisors

December 11, 1998

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014